Aquestive Therapeutics, Inc. 4

Julie Krop exercised 25,000 options at about $0.71 and sold 25,000 Aquestive Therapeutics (AQST) common shares at about $5.02 under a Rule 10b5-1 plan.

On June 23, 2026, Julie Krop, an insider of Aquestive Therapeutics, Inc., exercised 25,000 non-qualified stock options at an exercise price of approximately $0.7132 per share and simultaneously sold 25,000 shares of common stock at an average price of approximately $5.0157 per share under a pre-arranged Rule 10b5-1 trading plan, resulting in a value capture of roughly $107,500 before taxes and leaving her with no directly owned common shares reported after the transaction.

Filing Facts

CIK

1398733

Ticker

AQST

Form

4

Source Type

sec

Accession

0001214659-26-007677

Alert Tier

6